All News

Political fight intensifies between independent pharmacists and pharmacy benefit managers.

2003 Arxcel Prescription Benefit Research Survey.

Clinicians can now offer their patients the first targeted oral therapy to be approved for the treatment of non-small cell lung cancer (NSCLC). The FDA recently approved gefitinib (Iressa, AstraZeneca) as monotherapy for the treatment of patients with locally advanced or metastatic NSCLC after failure of both platinum-based and docetaxel chemotherapies. Gefitinib was reviewed and approved under the Agency?s accelerated approval program. The drug is currently available in pharmacies.

Instead of racking up hours of continuing education, pharmacists should build, implement and evaluate portfolios for continuing professional development and lifelong learning, according to the National Association of Boards of Pharmacy.

Nevada College of Pharmacy convenes symposium on the subject of Medicare drug benefit.

New IV pumps carry warnings to alert users about potential errors.

Chain execs attend the 70th Annual NACDS Meeting hoping to get answers to pressing questions facing pharmacy and their businesses.

For the second time in less than four years, a New Jersey patient who was undergoing chemotherapy at a hospital died because the drug was given via the wrong route of administration.

National Quality Forum upholds value of pharmacists in medication management.

Pharmacists hoping to become certified to train their diabetes patients to use insulin pumps must wear the devices themselves, under a project sponsored by Diabetes in Control.com.

An Arizona pharmacist claims she was fired for pumping breast milk on the job at Safeway.

At the 99th annual meeting of the National Association of Boards of Pharmacy, Food & Drug Administration officials urged state pharmacy boards to help the agency cope with the growing number of storefront operations facilitating illegal Rx drugs pouring into the U.S. from Canada.

Should pharmacists release protected health information to patients' relatives and friends?

If cuts in Medicaid reimbursement go through in New York, as proposed by the governor, many pharmacies in the state could go out of business.

New guidelines related to treatment of Type 2 diabetics with hypertension.

The Department of Labor is proposing a revision of regualtions under the Fair Labor Standards Act that would eliminate overtime pay for R.Ph.s.

Pharmacy groups want the FDA to take a uniform approach to risk management of prescription drugs.

Where else can you practice if your license is suspended in one state?

New Drug Checklist - Factive(Gemifloxacin) is a fluroquinolone antibiotic - used to treat bacterial lung infections.

Physicians will soon have a fourth-generation fluoroquinolone with dual activity against bacteria to treat persons with community-acquired respiratory infections. The FDA recently approved gemifloxacin (Factive, GeneSoft Pharmaceuticals) for the treatment of acute bacterial exacerbation of chronic bronchitis (AECB) caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, or Moraxella catarrhalis and community-acquired pneumonia (CAP) of mild-to-moderate severity caused by S. pneumoniae (including penicillin-resistant strains), H. influenzae, M. catarrhalis, Mycoplasma pneumoniae, Chlamydia pneumoniae, or Klebsiella pneumoniae. Gemifloxacin will be available in pharmacies by the end of the year.

Beginning in 2004, volunteer hospitals will get unannounced visits by JCAHO surveyors. By 2006, all healthcare organizations will be subject to surprise surveys.

Pharmacists' appearance is at issue.

U.S. regulators target the new gold rush--prescription drug imports from across the border.

The U.S. Supreme Court handed pharmacists and other healthcare providers a victory in a unanimous ruling upholding Kentucky's any-willing-provider laws.

A number of new products, including two under development, are providing women with a wide range of options in hormonal contraception.

Studies show that women have more severe and longer-lasting pain, men and women respond differently to pain medications, and more women are under-treated for pain.

The incidence of cardiovascular disease (CVD) in the United States outranks all other causes of morbidity and mortality. However, the perception still persists that CVD affects primarily men, and that women are somehow protected from it.

May's Drug Stores Chain of the Year 2003